Results of Low-Dose Human Atrial Natriuretic Peptide Infusion in Nondialysis Patients With Chronic Kidney Disease Undergoing Coronary Artery Bypass Grafting
Akira Sezai(Nihon University), Atsushi Hirayama(Nihon University), Isamu Yoshitake(Nihon University), Tetsuya Niino(Nihon University), Mitsumasa Hata(Nihon University), Tadateru Takayama(Nihon University), Haruka Kimura(Nihon University), Motomi Shiono(Nihon University), Shinji Wakui(Nihon University), Satoshi Unosawa(Nihon University)
Cited by 108
Related Papers
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|242
Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
|Circulation Journal|2013|120
Effects of Canagliflozin in Patients with Type 2 Diabetes and Chronic Heart Failure: A Randomized Trial (CANDLE)
|ESC Heart Failure|2020|109
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
|PLoS Medicine|2020|100
Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial
|Journal of Thoracic and Cardiovascular Surgery|2011|96